Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
via Google News
The Latest on: Shortages of life-saving drugs
- Industry Voices—Industry reaction to shortages of lifesaving drugs underscores urgencyon October 30, 2019 at 1:20 pm
Especially in cases of shortages for lifesaving drugs, doctors must implement conservative efforts to ensure the patients that need it the most get their medication. Today, more than 200 life-saving ...
- Congress, Grappling With Tainted Chinese Drugs, Is Baffled by Lack of FDA Oversight in U.S. Pharmaceutical Supply Chainon October 30, 2019 at 11:50 am
"The crippling inadequacy of the American drug supply." Eshoo went on to say that the U.S. generic-drug industry's reliance on foreign agents creates shortages of life-saving medications as well as ...
- Healthcare groups announce strong support for Mitigating Emergency Drug Shortages Acton October 29, 2019 at 2:20 pm
We look forward to working with Congress to advance the MEDS Act, which will help prevent, mitigate and resolve drug shortages and secure the supply of these life-saving products for patients and the ...
- 'Under threat': Why experts say U.S. import of Canadian drugs could put supply at riskon October 26, 2019 at 6:34 am
Drug shortages already have a "detrimental impact" on the delivery of patient care ... some Third World place': Bladder cancer patients face ongoing scarcity of life-saving drug "Very few of our drugs ...
- Texas hospitals scramble to cope with shortage of pediatric cancer drugon October 25, 2019 at 1:44 pm
... for which there needs to be policy changes or incentives to prevent future shortages of life-saving medications,” said Rabin. “These shortages can’t continue. They have a huge negative impact.” ...
- NC families get good news about shortage of life-saving cancer drug vincristineon October 24, 2019 at 8:40 pm
CHAPEL HILL, N.C. (WTVD) -- Ayden Locklear and his family are getting good news about a nationwide shortage of the life-saving cancer drug vincristine. Ayden is a 3-year-old who is getting treatment ...
- Cancer drug shortage could end sooner than expectedon October 21, 2019 at 7:50 pm
(WFLA) — A nationwide shortage of a crucial cancer drug could be over sooner than expected ... That means patients, like little Caleb Gaulin, may get their life-saving treatments sooner than expected.
- MD Anderson, Texas Children's scramble to cope with drug shortageon October 21, 2019 at 2:23 am
“While it is clear that the immediate concern and goal is to solve the issue surrounding vincristine, I believe the community should consider advocacy steps to help prevent future shortages of ...
- Parents of children with cancer speak up about critical drug shortageon October 20, 2019 at 9:11 am
The United States is facing a shortage of a critical drug used to treat children with cancer. As parents worry they won't be able to get the life-saving treatment for their children, doctors say the ...
- 'I'm just scared': Child fighting cancer admits fearing what drug shortage will mean for the battle aheadon October 18, 2019 at 9:57 pm
ATLANTA — Outrage is building across the country as children fighting cancer are denied life-saving medicine. These children know they aren't getting the medicine they need and they're scared. Now, ...
via Bing News